English | Español

Novartis
Patient Daily | May 7, 2023

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily | May 7, 2023

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Patient Daily | May 7, 2023

Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Patient Daily | May 7, 2023

Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Carol Ostrow | Feb 7, 2019

Novartis says Cosentyx better at clearing skin in psoriasis patients than Stelara
Press release submission | Dec 5, 2018

NOVARTIS: Announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers
Press releases submission | May 15, 2018

NOVARTIS: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Carrie Bradon | Dec 1, 2017

Novartis announces positive results of MONALEESA-7 trial

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments